Tag Archives: Research Programmes

NHS England Research and Development Strategy (NHS England)

Summary NHS England has a statutory responsibility to promote research, according to the NHS Constitution (2013), the Health and Social Care Act (2012) and the Mandate to NHS England. NHS England has released a draft research and development strategy. The … Continue reading

Posted in Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), National, NHS, NHS England, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Discovery Institute (Alzheimer’s Research UK)

Summary Alzheimer’s Research UK has announced proposals to create Europe’s first Drug Discovery Institute for neurodegenerative diseases including dementia. The aim of the multi-million pound Drug Discovery Institute will be to accelerate progress towards effective treatments for Alzheimer’s disease and other dementias. … Continue reading

Posted in Alzheimer’s Research UK, Charitable Bodies, For Researchers (mostly), International, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

G8 Dementia Summit Preamble Underway (Alzheimers Disease International)

Summary The G8 Dementia Summit, dedicated to tackling dementia research globally, takes place on December 11th 2013 in London. Alzheimers Disease International (ADI) will take part, along with the Alzheimer’s Society (UK), the Alzheimer’s Association (US), amongst others. “The summit will … Continue reading

Posted in Alzheimer's Society, Alzheimer’s Disease International (ADI), Charitable Bodies, For Researchers (mostly), International, NIHR, Non-Pharmacological Treatments, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Health Technology Assessment)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 11, June 2012]. Summary The purpose of this Health Technology Assessment was to review and update guidance to the NHS in England and Wales … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NHS, NIHR, Pharmacological Treatments, Proposed for Next Newsletter, Systematic Reviews, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment